ArticleScientific reports2025
Biospectroscopy screening and molecular fingerprinting of gastric cancer cases from biofluids by vibrational spectroscopy allied with chemometrics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk Phenotyping Before Graft Implantation: FTIR Spectroscopy and Machine Learning for Complementary Risk Stratification in Kidney Transplantation.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The present study aims to develop a new molecular diagnostic modality based upon mid-infrared (mid-IR) spectroscopy allied with chemometrics for the diagnosis of gastric cancer (GC) from diverse biofluids. The characterization over the spectral data specified the changes at molecular level caused from the synthesis of main biomolecules like lipids, proteins and carbohydrates was performed. The spectral data from the cancer and their control cases were analyzed by practicing the supervised and unsupervised chemometrics analysis including PCA, SIMCA, LDA and HCA. The results indicated that remarkable changes were occurred in the content of biomolecules for GC cases due to energy necessities. 100% of the cancer cases from blood serum, blood plasma and saliva biofluids were successfully discriminated from their control specimens by LDA. Consequently, this research established the potential of mid-IR spectroscopy allied with chemometrics for evaluating biochemical changes of GC cases with high sensitivity and precision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.